Tag: Andrew Percy

The below Parliamentary question was asked by Andrew Percy on 2015-10-26.

To ask the Secretary of State for Education, how many defibrillators have been purchased by new schools nationally in accordance with guidance issued in 2014 by her Department; and what assessment she has made of the effect of this guidance.

Edward Timpson

The Department does not hold information on the number of schools which have staff trained in CPR. All schools should have at least one first-aider, and the number of first-aid personnel will be based on local circumstances, considered as part of a first aid needs assessment in the school. Recognised certificated courses ‘First Aid at Work’ or ‘Emergency First Aid at Work’ train staff in the administration of CPR.

The guidance published by the Department in November 2014 promoted a scheme to enable schools to purchase defibrillators at reduced cost. As of 23 October 2015, 735 defibrillators had been purchased by schools through this scheme. The Department does not hold information on the total number of schools with a defibrillator.

The below Parliamentary question was asked by Andrew Percy on 2015-10-26.

To ask the Secretary of State for Education, how many schools in England have (a) staff trained in CPR or (b) a defibrillator on site; and what plans her Department has to ensure that all schools have (i) such staff and (ii) on-site defibrillators.

Edward Timpson

The Department does not hold information on the number of schools which have staff trained in CPR. All schools should have at least one first-aider, and the number of first-aid personnel will be based on local circumstances, considered as part of a first aid needs assessment in the school. Recognised certificated courses ‘First Aid at Work’ or ‘Emergency First Aid at Work’ train staff in the administration of CPR.

The guidance published by the Department in November 2014 promoted a scheme to enable schools to purchase defibrillators at reduced cost. As of 23 October 2015, 735 defibrillators had been purchased by schools through this scheme. The Department does not hold information on the total number of schools with a defibrillator.

The below Parliamentary question was asked by Andrew Percy on 2015-10-26.

To ask the Secretary of State for the Home Department, what assessment she has made of the success of her Department’s policies in supporting the UK Border Force to tackle illegal immigration into the UK.

James Brokenshire

Ensuring the security of the UK’s borders and tackling illegal immigration is a priority for the Government. We keep all policies under review to ensure effectiveness.

The new Immigration Bill contains measures designed to reform the UK’s immigration system, to prevent abuse and the flouting of the law by people who should not be here. The Bill will help secure the border, support working people, clamp down on illegal immigration and protect our public services, and tackle the exploitation of low-skilled workers and increase sanctions for those involved in such practices.

The below Parliamentary question was asked by Andrew Percy on 2015-02-10.

To ask the Secretary of State for Health, pursuant to the Answers of 2 February 2015 to Questions 222495, 222494 and 222493, how many medicines were paid for by the industry rebate payments through the Pharmaceutical Price Regulation Scheme in 2014 in each (a) financial quarter and (b) therapeutic area.

George Freeman

The Mandate for 2015-16 has set a firm NHS England budget for 2015-16, which is £3 billion (3%) higher than its budget for 2014-15. This increase takes into account a number of things, including additional funding for the National Health Service announced in the Autumn Statement and the fact that the Pharmaceutical Price Regulation Scheme (PPRS) payment in 2015-16 is now forecast to be higher than originally expected.

All the PPRS payments go back into spending on improving patients’ health and care and it will be up to NHS England how they split that overall budget between clinical commissioning groups, specialised commissioning etc. Following normal Government accounting rules, there is no separately identified ring-fenced funding stream associated with the PPRS payment. Accordingly, it would not be possible to identify what or how many medicines are paid for by PPRS payments.

The Government believes that NHS commissioners and providers are best placed to decide how to allocate their budgets to deliver improvements in the outcomes for patients. The PPRS includes a number of commitments for improving patient outcomes and for improving patient access to clinically and cost effective medicines.

The below Parliamentary question was asked by Andrew Percy on 2015-02-10.

To ask the Secretary of State for Health, pursuant to the Answer of 2 February 2015 to Question 222493, what records NHS England keeps of the medicines that are paid for by the industry rebate payments through the Pharmaceutical Price Regulation Scheme.

George Freeman

The Mandate for 2015-16 has set a firm NHS England budget for 2015-16, which is £3 billion (3%) higher than its budget for 2014-15. This increase takes into account a number of things, including additional funding for the National Health Service announced in the Autumn Statement and the fact that the Pharmaceutical Price Regulation Scheme (PPRS) payment in 2015-16 is now forecast to be higher than originally expected.

All the PPRS payments go back into spending on improving patients’ health and care and it will be up to NHS England how they split that overall budget between clinical commissioning groups, specialised commissioning etc. Following normal Government accounting rules, there is no separately identified ring-fenced funding stream associated with the PPRS payment. Accordingly, it would not be possible to identify what or how many medicines are paid for by PPRS payments.

The Government believes that NHS commissioners and providers are best placed to decide how to allocate their budgets to deliver improvements in the outcomes for patients. The PPRS includes a number of commitments for improving patient outcomes and for improving patient access to clinically and cost effective medicines.

The below Parliamentary question was asked by Andrew Percy on 2015-02-11.

To ask the Secretary of State for Health, whether his Department has conducted a study on the viability of a New Medicines Fund for England.

George Freeman

We have no plans to do so.

On 12 January 2015, NHS England announced that it plans to further increase the level of investment for drugs in the Cancer Drugs Fund to an expected £340 million in 2015-16.

The Government is implementing all of the commitments in the 2014 Pharmaceutical Price Regulation Scheme (PPRS) on improving access to innovative medicines commensurate with the outcomes they offer patients. In addition, NHS England and the Association of the British Pharmaceutical Industry are pressing ahead with plans to maximise the benefits of the PPRS by improving access to and optimising the use of medicines to improve patient outcomes.

More generally, we have launched an ‘Innovative Medicines and Medical Technology Review’ of the pathways for the development, assessment, and adoption of innovative medicines and medical technology. This review will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices. The review will examine the pathway from ‘first in human’ trials, through licensing and health technology appraisal, to commissioning and clinical practice. It will set out both short and long-term options for action by Government and relevant bodies, including the National Institute for Health and Care Excellence, the Medicines and Healthcare products Regulatory Agency and NHS England, and mark a major contribution to the policy debate.